49
Views
17
CrossRef citations to date
0
Altmetric
Original Articles

Latest therapies for bipolar disorder

Looking beyond lithium

, MD & , MD, MPH
Pages 25-36 | Published online: 30 Jun 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Leslie Citrome & Betty Vreeland. (2008) Schizophrenia, Obesity, and Antipsychotic Medications: What Can We Do?. Postgraduate Medicine 120:2, pages 18-33.
Read now
Roger S McIntyre, Hanna O Woldeyohannes, Batya S Yasgur, Joanna K Soczynska, Andrew Miranda & Jakub Z Konarski. (2007) Maintenance treatment in bipolar disorder: a focus on aripiprazole. Expert Review of Neurotherapeutics 7:8, pages 919-925.
Read now
Joseph C Blader & Vivian Kafantaris. (2007) Pharmacological treatment of bipolar disorder among children and adolescents. Expert Review of Neurotherapeutics 7:3, pages 259-270.
Read now

Articles from other publishers (14)

. 2019. Therapie psychischer Erkrankungen. Therapie psychischer Erkrankungen 1 119 .
. 2017. Therapie psychischer Erkrankungen. Therapie psychischer Erkrankungen 1 111 .
Zhi Peng Wen, Shuang Shi Fan, Can Du, Tao Yin, Bo Ting Zhou, Ze Feng Peng, Yuan Yang Xie, Wei Zhang, Yao Chen, Jie Tang, Jian Xiao & Xiao Ping Chen. (2016) Influence of acylpeptide hydrolase polymorphisms on valproic acid level in Chinese epilepsy patients. Pharmacogenomics 17:11, pages 1219-1225.
Crossref
. 2015. Therapie Psychischer Erkrankungen. Therapie Psychischer Erkrankungen e1 e96 .
. 2014. Therapie Psychischer Erkrankungen. Therapie Psychischer Erkrankungen 1 91 .
Marcus T. Silva, Ivan R. Zimmermann, Tais F. Galvao & Mauricio G. Pereira. (2013) Olanzapine plus fluoxetine for bipolar disorder: A systematic review and meta-analysis. Journal of Affective Disorders 146:3, pages 310-318.
Crossref
Seong S. Shim, Michael D. Hammonds, Curtis Tatsuoka & I. Jung Feng. (2012) Effects of 4-weeks of treatment with lithium and olanzapine on long-term potentiation in hippocampal area CA1. Neuroscience Letters 524:1, pages 5-9.
Crossref
Ute Lewitzka & Michael Bauer. 2012. Handbuch der Psychopharmakotherapie. Handbuch der Psychopharmakotherapie 993 1004 .
Mohamad Karouni, Subaneesan Arulthas, Pål G. Larsson, Elisif Rytter, Svein I. Johannessen & Cecilie Johannessen Landmark. (2010) Psychiatric comorbidity in patients with epilepsy: a population-based study. European Journal of Clinical Pharmacology 66:11, pages 1151-1160.
Crossref
Michael D. Hammonds & Seong S. Shim. (2009) Effects of 4-week Treatment with Lithium and Olanzapine on Levels of Brain-derived Neurotrophic Factor, B-Cell CLL/Lymphoma 2 and Phosphorylated Cyclic Adenosine Monophosphate Response Element-binding Protein in the Sub-regions of the Hippocampus. Basic & Clinical Pharmacology & Toxicology 105:2, pages 113-119.
Crossref
Kavi K. Devulapalli & Henry A. Nasrallah. (2009) An analysis of the high psychotropic off-label use in psychiatric disorders. Asian Journal of Psychiatry 2:1, pages 29-36.
Crossref
Etienne Marc Grandjean & Jean-Michel Aubry. (2009) Lithium: Updated Human Knowledge Using an Evidence-Based Approach. CNS Drugs 23:3, pages 225-240.
Crossref
Michael D. Stensland, Jennie G. Jacobson & Allen Nyhuis. (2007) Service utilization and associated direct costs for bipolar disorder in 2004: An analysis in managed care. Journal of Affective Disorders 101:1-3, pages 187-193.
Crossref
Hani R. Khouzam. 2007. Handbook of Emergency Psychiatry. Handbook of Emergency Psychiatry 157 183 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.